IPA predicted the up- and downregulation of several immunomodulatory molecules at both timepoints (Fig. 3c), including FGF2, which is known to support ZIKV infection by suppressing IFN signaling (Limonta et al., 2019). The gene discussed is IFNA1; the disease is Zika virus infectious disease.